GlassScriptPhysician profile
Jacqueline Monroe
NPI 1912276361
$3,675.50
in general payments reported to CMS, 2019-2025
35 companies · $85.33 in 2025
The $85.33 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $436 · 2020: $449 · 2021: $718 · 2022: $1,036 · 2023: $309 · 2024: $642 · 2025: $85.33.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,036.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,035.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $524.91 | 2020-2025 | Renasys, Regranex, Pico 7 |
| Boston Scientific Corporation | $523.21 | 2021-2024 | |
| Organogenesis INC. | $512.07 | 2019-2024 | |
| Nevro Corp. | $446.05 | 2022-2024 | Senza |
| Sandoz INC. | $301.28 | 2019-2020 | |
| Medtronic, INC. | $260.04 | 2022-2024 | Intellis Adaptivestim |
| Horizon Therapeutics Plc | $146.02 | 2019-2023 | Krystexxa |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $109.04 | 2020-2024 | Jublia |
| Treace Medical Concepts, INC. | $97.34 | 2022-2024 | |
| Depuy Synthes Sales INC. | $71.82 | 2020-2024 | N/A |
| Grt US Holding, INC. | $61.35 | 2021 | |
| Abbvie INC. | $53.60 | 2023 | |
| Stryker Corporation | $46.61 | 2019 | |
| Orthofix Medical, INC. | $43.36 | 2019-2021 | |
| Integra Lifesciences Corporation | $38.65 | 2019 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $36.94 | 2022-2023 | Nuzyra |
| Linvatec Corporation | $33.95 | 2024 | Biobrace 23mm |
| Anika Therapeutics, INC. | $32.10 | 2021 | |
| Nabriva Therapeutics, Plc | $31.79 | 2021-2022 | |
| Dynasplint Systems INC. | $30.02 | 2019-2023 | Dynasplint |
| Averitas Pharma INC. | $29.72 | 2024 | Qutenza |
| Tactile Systems Technology INC | $29.60 | 2020-2024 | Flexitouch Plus, Entre Plus |
| Arthrosurface Incorporated | $28.86 | 2019 | |
| Djo, LLC | $25.11 | 2021 | |
| Alfasigma USA, INC. | $24.27 | 2020-2021 | |
| Acera Surgical, INC. | $15.38 | 2022 | |
| Osiris Therapeutics INC. | $14.90 | 2019 | |
| Paragon 28, INC. | $14.87 | 2025 | Grappler |
| Celularity INC. | $14.00 | 2019 | |
| Sanara Medtech INC. | $13.57 | 2021 | |
| Medline Industries LP | $13.56 | 2019 | |
| Amgen INC. | $13.53 | 2025 | Krystexxa |
| Bioventus LLC | $13.32 | 2023 | |
| Kowa Pharmaceuticals America, INC. | $12.87 | 2022 | |
| Triad Life Sciences INC. | $11.79 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacqueline Monroe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.